Evidence map›Paper›PMID 31857376›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2020

Racial and Ethnic Variations in Mortality Rates for Patients Undergoing Maintenance Dialysis Treated in US Territories Compared with the US 50 States.

Guofen Yan, Jenny I Shen, Rubette Harford, Wei Yu, Robert Nee, Mary Jo Clark, Jose Flaque, Jose Colon, Francisco Torre, Ylene Rodriguez and 3 more

Open access · bronzeAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Guofen YanDepartment of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia; guofen.yan@virginia.edu knorris@ucla.edu.
Jenny I ShenDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.ORCID 0000-0002-2993-403X
Rubette HarfordSchool of Nursing, Mount St. Mary's University, Los Angeles, California.
Wei YuDepartment of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia.
Robert NeeDepartment of Nephrology, Walter Reed National Military Medical Center, Uniformed Services University, Bethesda, Maryland.
Mary Jo ClarkHahn School of Nursing and Health Science, University of San Diego, San Diego, California; and.
Jose FlaqueAtlantis Healthcare Group-Puerto Rico, Trujillo Alto, Puerto Rico.
Jose ColonAtlantis Healthcare Group-Puerto Rico, Trujillo Alto, Puerto Rico.
Francisco TorreAtlantis Healthcare Group-Puerto Rico, Trujillo Alto, Puerto Rico.
Ylene RodriguezAtlantis Healthcare Group-Puerto Rico, Trujillo Alto, Puerto Rico.
Jane GeorgesHahn School of Nursing and Health Science, University of San Diego, San Diego, California; and.
Lawrence AgodoaNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Keith C NorrisDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California; guofen.yan@virginia.edu knorris@ucla.edu.ORCID 0000-0003-3071-0700
University of California, Los Angeles · USUniversity of San Diego · USUniversity of Virginia · USMount St. Mary's University · USNational Institutes of Health · USWalter Reed National Military Medical Center · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
The Center for Health Improvement of Minority ElderlyP30AG021684 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Homero Erwin del Pino · 2002 to 2026
$19.7M
UCLA Clinical and Translational Science InstituteKL2TR000122 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$4.5M
Obesity Health Disparities Research PRIDE Program (OHD PRIDE)R25HL126145 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI BEECH, BETTINA M., BRUCE, MARINO A · 2014 to 2025
$3.9M
Racial and ethnic disparities in kidney outcomes among people at risk for chronic kidney disease (CKD)R01DK112008 · NIDDK · UNIVERSITY OF VIRGINIA · PI Julia J Scialla, Guofen Yan · 2018 to 2026
$2.2M
Trajectories of Adherence to Cardiovascular Medications in Patients on DialysisK23DK103972 · NIDDK · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI SHEN, JENNY I · 2015 to 2019
$934k
NCATS NIH HHS KL2 TR000122NCATS NIH HHS UL1 TR000124NHLBI NIH HHS R25 HL126145NIA NIH HHS P30 AG021684NIDDK NIH HHS K23 DK103972NIDDK NIH HHS R01 DK112008
6 · The paper itself

Abstract

BACKGROUND AND

objectivesIn the United States mortality rates for patients treated with dialysis differ by racial and/or ethnic (racial/ethnic) group. Mortality outcomes for patients undergoing maintenance dialysis in the United States territories may differ from patients in the United States 50 states. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective cohort study of using US Renal Data System data included 1,547,438 adults with no prior transplantation and first dialysis treatment between April 1, 1995 and September 28, 2012. Cox proportional hazards regression was used to calculate hazard ratios (HRs) of death for the territories versus 50 states for each racial/ethnic group using the whole cohort and covariate-matched samples. Covariates included demographics, year of dialysis initiation, cause of kidney failure, comorbid conditions, dialysis modality, and many others.

resultsOf 22,828 patients treated in the territories (American Samoa, Guam, Puerto Rico, Virgin Islands), 321 were white, 666 were black, 20,299 were Hispanic, and 1542 were Asian. Of 1,524,610 patients in the 50 states, 838,736 were white, 444,066 were black, 182,994 were Hispanic, and 58,814 were Asian. The crude mortality rate (deaths per 100 patient-years) was lower for whites in the territories than the 50 states (14 and 29, respectively), similar for blacks (18 and 17, respectively), higher for Hispanics (27 and 16, respectively), and higher for Asians (22 and 15). In matched analyses, greater risks of death remained for Hispanics (HR, 1.65; 95% confidence interval, 1.60 to 1.70;

conclusionsMortality rates for patients undergoing dialysis in the United States territories differ substantially by race/ethnicity compared with the 50 states. After matched analyses for comparable age and risk factors, mortality risk no longer differed for whites or blacks, but remained much greater for territory-dwelling Hispanics and Asians.

Indexed as

AsianHealth Status DisparitiesHispanic or LatinoKidney DiseasesAdultAgedAged, 80 and overBlack or African AmericanFemaleHealthcare DisparitiesHumansMaleMiddle AgedPacific IslandsPuerto RicoRace FactorsadultsAmerican SamoaAsian Continental Ancestry Groupconfidence intervalsContinental population groupsdialysisend stage kidney diseaseethnic groupsGuamHispanic AmericanshumansislandsmortalityPuerto RicoRacial/Ethnic Minoritiesrenal dialysisrenal insufficiencyretrospective studiesrisk factorsUnited StatesU.S. territories

Identifiers

PMID31857376
PMCPMC6946070
OpenAlexW2995850466

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.